Search Results - "Cohen, JA"

Distal symmetric polyneuropathy: A definition for clinical research : Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation by ENGLAND, J. D, GRONSETH, G. S, LATOV, N, LEWIS, R. A, LOW, P. A, SUMNER, A. J, FRANKLIN, G, MILLER, R. G, ASBURY, A. K, CARTER, G. T, COHEN, J. A, FISHER, M. A, HOWARD, J. F, KINSELLA, L. J

“…The objective of this report was to develop a case definition of distal symmetric polyneuropathy to standardize and facilitate clinical research and…”
Get full text

Differential diagnosis of suspected multiple sclerosis: a consensus approach by Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

“…Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings…”
Get full text

The Potential for Vigabatrin‐Induced Intramyelinic Edema in Humans by Cohen, Jeffrey A., Fisher, Robert S., Brigell, Mitchell G., Peyster, Robert G., Sze, Gordon

“…Purpose: Vigabatrin (Sabril, Hoechst Marion Roussel) is an antiepilepsy drug (AED) presently marketed in 64 countries for the treatment of partial and…”
Get full text

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis by Cohen, Jeffrey A., Chun, Jerold

“…Until recently, all approved multiple sclerosis (MS) disease treatments were administered parenterally. Oral fingolimod was approved in September 2010 by the…”
Get full text

Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas by Cohen, Jill A, Geradts, Joseph

“…The product of the MTS1/CDKN2 gene (p16) and the retinoblastoma protein (pRB) inhibit cell cycle progression at the late Gl check-point. The absence of…”
Get full text

Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls by Goldman, Myla D, Marrie, Ruth Ann, Cohen, Jeffrey A

“…Objective To assess the characteristics of the 6-min walk (6MW) in multiple sclerosis (MS) subjects of varied disability, and controls. To assess the…”
Get full text

Sumatriptan treatment for migraine in a health maintenance organization: Economic, humanistic, and clinical outcomes by Cohen, Jeffrey A., Beall, Donna, Beck, Arne, Rawlings, Julia, Miller, David W., Clements, Bill, Pait, D. Gayla, Batenhorst, Alice

“…This study was undertaken to assess the impact of 12 months of sumatriptan therapy (6 mg subcutaneously) for migraine on health care use, health-related…”
Get full text

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis by Vollmer, T. L., Sorensen, P. S., Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., Arnold, D. L.

“…The phase III placebo-controlled BRAVO study assessed laquinimod effects in patients with relapsing-remitting MS (RRMS), and descriptively compared laquinimod…”
Get full text

Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy by Francis, G, Kappos, L, O’Connor, P, Collins, W, Tang, D, Mercier, F, Cohen, JA

“…Background: Reduction in peripheral blood lymphocytes is an expected pharmacodynamic outcome of fingolimod therapy. Objective: The objective of this article is…”
Get full text

A Multisite, Randomized Controlled Trial for Children with Sexual Abuse-Related PTSD Symptoms by Cohen, Judith A, Deblinger, Esther, Mannarino, Anthony P, Steer, Robert A

“…Objective: To examine the differential efficacy of trauma-focused cognitive-behavioral therapy (TF-CBT) and child-centered therapy for treating posttraumatic…”
Get more information

Combination therapy in multiple sclerosis by Conway, Devon, MD, Cohen, Jeffrey A, MD

“…Summary Multiple sclerosis (MS) is an autoimmune disease of the CNS. It is the most common non-traumatic cause of neurological disability among young adults in…”
Get full text

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation by England, J D, Gronseth, G S, Franklin, G, Carter, G T, Kinsella, L J, Cohen, J A, Asbury, A K, Szigeti, K, Lupski, J R, Latov, N, Lewis, R A, Low, P A, Fisher, M A, Herrmann, D N, Howard, Jr, J F, Lauria, G, Miller, R G, Polydefkis, M, Sumner, A J

“…Distal symmetric polyneuropathy (DSP) is the most common variety of neuropathy. Since the evaluation of this disorder is not standardized, the available…”
Get full text

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation by England, J D, Gronseth, G S, Franklin, G, Carter, G T, Kinsella, L J, Cohen, J A, Asbury, A K, Szigeti, K, Lupski, J R, Latov, N, Lewis, R A, Low, P A, Fisher, M A, Herrmann, D N, Howard, Jr, J F, Lauria, G, Miller, R G, Polydefkis, M, Sumner, A J

“…Distal symmetric polyneuropathy (DSP) is the most common variety of neuropathy. Since the evaluation of this disorder is not standardized, the available…”
Get full text

Treating sexually abused children: 1 year follow-up of a randomized controlled trial by Cohen, Judith A., Mannarino, Anthony P., Knudsen, Kraig

“…To measure the durability of improvement in response to two alternative treatments for sexually abused children. Eighty-two sexually abused children ages 8–15…”
Get full text

A Pilot Randomized Controlled Trial of Combined Trauma-Focused CBT and Sertraline for Childhood PTSD Symptoms by COHEN, JUDITH A., M.D, MANNARINO, ANTHONY P., Ph.D, PEREL, JAMES M., Ph.D, STARON, VIRGINIA, M.S

“…ABSTRACT Objective To examine the potential benefits of adding a selective serotonin reuptake inhibitor, sertraline, versus placebo, to trauma-focused…”
Get full text

Trauma in children and adolescents: risk and treatment of psychiatric sequelae by Pine, Daniel S, Cohen, Judith A

“…The recent wave of terrorism affecting the United States and other countries raises concerns about the welfare of children and adolescents. This review is…”
Get full text

Dose comparison trial of sustained-release fampridine in multiple sclerosis by GOODMAN, A. D, BROWN, T. R, COHEN, J. A, KRUPP, L. B, SCHAPIRO, R, SCHWID, S. R, COHEN, R, MARINUCCI, L. N, BLIGHT, A. R

“…To examine the efficacy and safety of three different doses of sustained-release fampridine in people with multiple sclerosis (MS). This multicenter,…”
Get full text

Autonomic nervous system involvement in patients with human immunodeficiency virus infection by COHEN, J. A, LAUDENSLAGER, M

“…We used an autonomic nervous system (ANS) testing battery to determine whether ANS dysfunction occurred in HIV infection. Five of 10 seropositive (HIV+)…”
Get full text

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program by Havrdova, Eva, Cohen, Jeffrey A, Horakova, Dana, Kovarova, Ivana, Meluzinova, Eva

“…The introduction of high-efficacy therapies for relapsing-remitting multiple sclerosis has driven re-evaluation of treatment goals and benefit:risk…”
Get full text

Treating Childhood Traumatic Grief: A Pilot Study by Cohen, Judith A, Mannarino, Anthony P, Knudsen, Kraig

“…Objective: To examine the potential efficacy and specific timing of treatment response of individual child and parent trauma-focused cognitive-behavioral…”
Get more information